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bstract
SARS coronavirus (SARS-CoV) emerged in 2002 as an important cause of severe lower respiratory tract infection in humans and in vitro models 
f the lung are needed to elucidate cellular targets and the consequences of viral infection. The severe and sudden onset of symptoms, resulting in an 
typical pneumonia with dry cough and persistent high fever in cases of severe acute respiratory virus brought to light the importance of coronaviruses 
s potentially lethal human pathogens and the identification of several zoonotic reservoirs has made the reemergence of new strains and future 
pidemics all the more possible. In this chapter, we describe the pathology of SARS-CoV infection in humans and explore the use of two models of 
he human conducting airway to develop a better understanding of the replication and pathogenesis of SARS-CoV in relevant in vitro systems. The 
rst culture model is a human bronchial epithelial cell line Calu-3 that can be inoculated by viruses either as a non-polarized monolayer of cells or 
olarized cells with tight junctions and microvilli. The second model system, derived from primary cells isolated from human airway epithelium and 
rown on Transwells, form a pseudostratified mucociliary epithelium that recapitulates the morphological and physiological features of the human 
onducting airway in vivo. Experimental results using these lung epithelial cell models demonstrate that in contrast to the pathology reported in late 
tage cases SARS-CoV replicates to high titers in epithelial cells of the conducting airway. The SARS-CoV receptor, human angiotensin 1 converting 
nzyme 2 (hACE2), was detected exclusively on the apical surface of cells in polarized Calu-3 cells and human airway epithelial cultures (HAE), indi-
ating that hACE2 was accessible by SARS-CoV after lumenal airway delivery. Furthermore, in HAE, hACE2 was exclusively localized to ciliated 
irway epithelial cells. In support of the hACE2 localization data, the most productive route of inoculation and progeny virion egress in both polar-
zed Calu-3 and ciliated cells of HAE was the apical surface suggesting mechanisms to release large quantities of virus into the lumen of the human 
ung. Preincubation of the apical surface of cultures with antisera directed against hACE2 reduced viral titers by two logs while antisera against DC-
IGN/DC-SIGNR did not reduce viral replication levels suggesting that hACE2 is the primary receptor for entry of SARS-CoV into the ciliated cells 
f HAE cultures. To assess infectivity in ciliated airway cultures derived from susceptible animal species we generated a recombinant SARS-CoV by 
eletion of open reading frame 7a/7b (ORF 7a/7b) and insertion of the green fluorescent protein (GFP) resulting in SARS-CoV GFP. SARS-CoV GFP 
eplicated to similar titers as wild type viruses in Vero E6, MA104, and CaCo2 cells. In addition, SARS-CoV replication in airway epithelial cultures 
enerated from Golden Syrian hamster tracheas reached similar titers to the human cultures by 72 h post-infection. Efficient SARS-CoV infection of 
iliated cell-types in HAE provides a useful in vitro model of human lung origin to study characteristics of SARS-CoV replication and pathogenesis. 
eywords: Human airway epithelia; SARS-CoV; Coronavirus replication; SARS-CoV GFP; Coronavirus pathogenesis
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i. IntroductionThe importance of human coronaviruses (HCoV) as
athogens that produce severe human respiratory diseases has
een greatly emphasized with the identification of the SARS-
oV and relevant model systems are needed to elucidate
he underlying molecular mechanisms governing coronavirus
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oi:10.1016/j.virusres.2007.03.013athogenesis and virulence in the human lung. SARS-CoV
nfection is an attractive model for HCoV infection as it pro-
uces severe disease in the human lung, replicates efficiently
n vitro, reverse genetics systems are available to identify the
enetic determinants governing pathogenesis and virulence, and
variety of animal models are under development (Almazan etl., 2006; Lawler et al., 2006; Martina et al., 2003; McCray et
l., 2006; Osterhaus et al., 2004; Roberts et al., 2005a,b; Tseng
t al., 2006; Yount et al., 2003). In this article we will provide a
rief review of the pathology of SARS-CoV infection as well as
ri
e
t
(
f
w
a
t
w
c
C
a
v
2
a
a
a
i
S
d
f
2
S
(
2
t
f
s
f
T
t
o
m
w
2
t
a
d
M
t
t
a
w
(
N
o
d
d
c
v
I
f
h
r
t
g
h
w
a
S
c
h
b
c
s
b
a
e
d
s
f
C
(
h
d
t
s
(
i
c
s
m
t
c
o
3
c
3
C
r
a
C
C
p
h
m
a
p
i
i
weviewing research examining human coronavirus infection of
n vitro models of the human conducting airway. Finally, we will
xtend current data on the characterization of SARS-CoV infec-
ion of an in vitro culture system of human airway epithelium
HAE) that recapitulates the morphological and physiological
eatures of the human conducting airway in vivo to determine
hether infection and spread of SARS-CoV throughout the cili-
ted conducting airway may be a valid model for understanding
he pathogenesis of SARS-CoV lung disease.
SARS-CoV caused about 8000 cases and ∼800 deaths world-
ide with a ∼10% overall mortality rate prior to successful
ontainment of the epidemic. Mortality rates following SARS-
oV infection approached <1% under 24 years of age, 6% for
ges 15–44, 15% for ages 45–64 and >50% over 65, and sur-
ivors developed lung and cardiac complications (Han et al.,
003). The disease caused by this pathogenic human coron-
virus is in stark contrast to that seen with other strains (229E
nd OC43), which produce only mild common cold symptoms,
lthough more serious disease has been reported in infants and
ndividuals with underlying co-morbidities (Pene et al., 2003).
ARS-CoV has been isolated from humans, civet cats, raccoon
ogs, swine and bats, suggesting that several animal species may
unction as natural reservoirs for future outbreaks (Guan et al.,
003). The Chinese horseshoe bat, which is abundant across
outheast Asia, is probably the natural reservoir for SARS-CoV
Guan et al., 2003; Lau et al., 2005; Li et al., 2005; Poon et al.,
005). Importantly, bats and bat products are used in food and
raditional medicine markets in southern China and Asia and bat
eces are used in traditional Chinese medicines providing a con-
tant source of human exposure to bats and bat tissues making
uture SARS or SARS-like outbreaks more likely (Fujita, 1988).
he SARS-CoV epidemic is the best characterized in terms of
he changes that likely evolved following initial introduction
f mildly virulent zoonotic strains into human populations, to
oderate and highly virulent isolates that circulated around the
orld in less than 6 months (Chinese, 2004).
. Clinical evidence for SARS-CoV pathogenesis
The predominant pathological features of SARS-CoV infec-
ion of the human lung include diffuse alveolar damage (DAD),
typical pneumonia with dry cough, persistent fever, progressive
yspnea and sometimes, abrupt deterioration of lung function.
ajor pathologic lesions include inflammatory exudation in
he alveoli and interstitial tissue with hyperplasia of fibrous
issue and fibrosis. These represent major histologic changes
ssociated with acute respiratory distress syndrome (ARDS),
hich has a high mortality rate and few treatment options
Cheung et al., 2004; Ksiazek et al., 2003; Kuiken et al., 2003;
icholls and Peiris, 2005). Increasing age, male sex, presence
f co-morbidity, high early viral RNA burdens, and high lactate
ehydrogenase (LDH) levels are associated with greater risk of
eath (Chu et al., 2004; Leung and Chiu, 2004). Using fluores-
ence in situ hybridization and tissue from fatal cases of disease,
irus was localized within alveolar pneumocytes (primarily type
I) and within alveolar spaces. Previously, the reported receptor
or SARS-CoV, the angiotensin 1 converting enzyme 2 (hACE2)
I
i
a
aad only been localized to alveolar cells in the lung although
ecent evidence indicates that hACE2 is present throughout
he human airway epithelium suggesting additional cellular tar-
ets of infections (Jia et al., 2005). SARS-CoV specific RNA
as also been localized in pulmonary macrophages although
hether viable virus was present was not determined (Lu et
l., 2005). In another study based on six patients who died from
ARS the most pronounced morphological features were giant
ell formation (predominately macrophages) and pneumocyte
yperplasia suggesting that proinflammatory cytokines released
y stimulated macrophages in the alveolus were a predominant
ause of pathogenesis (Nicholls et al., 2003a,b). Histological
amples for determining SARS-CoV infection of airways have
een less rigorously studied as pathological analyses is usu-
lly performed on late stage fatal cases (Chow et al., 2004; To
t al., 2004). However, early disease noted marked bronchiolar
isease with respiratory epithelial cell necrosis, loss of cilia,
quamous metaplasia and intrabronchiolar fibrin deposits. In
act it has been suggested that early DAD as a result of SARS-
oV infection may initiate within the respiratory bronchioles
Franks et al., 2003; Nicholls et al., 2003a,b). It has also been
ypothesized that SARS-CoV replication in the human con-
ucting airway may be cell type restricted by expression of
he receptor/co-receptor molecules hACE2 and dendritic cell-
pecific ICAM3-grabbing nonintegrin (DCSIGN/DCSIGNR)
Jeffers et al., 2004). DCSIGNR expression is readily detectable
n alveolar type II cells the major cell type infected in the fatal
ases of SARS infection. In vitro replication and pathogene-
is models of the human conducting airway would provide a
echanism to determine all SARS coronavirus permissive cell
ypes in the lung at earlier times post-infection and will provide
lues about disease progression and potentially predict severity
f disease outcome.
. Coronavirus replication in models of the human
onducting airway
.1. SARS-CoV infection of monolayers and polarized
alu-3 cells
Several studies have been performed to identify SARS-CoV
eplication-competent in vitro models of the human conducting
irway epithelium. Tseng et al. (2005) published the first SARS-
oV in vitro replication model using monolayers and polarized
alu-3 cells. Calu-3 cells were originally isolated from a human
ulmonary adenocarcinoma and are characterized as nonciliated
uman lung/bronchial epithelial cells. Following inoculation of
onolayers of Calu-3 cells; SARS-CoV replication was detected
s early as 24 h post-infection with peak titers occurring at 48 h
ost-infection (∼5 × 106 TCID50, Table 1). However, virus
nduced cytopathic effect was not detected until 8 days post-
noculation. Viral titer results were confirmed by real time PCR;
ith peak viral RNA detection occurring 48 h post-inoculation.mmunofluorescence assays using convalescent human serum
solated from a SARS-CoV infected patient detected SARS-CoV
ntigens in foci on the Calu-3 monolayers demonstrating that not
ll cells were productively infected. Dual labeling immunfluo-
Table 1
Respiratory virus replication in models of the human conducting airway
Virus Cell type Apical inoculation (APh) Apical inoculation (BAi) Basolateral inoculation (AP) Basolateral inoculation (BA)
SARSa Calu-3 (Mono) ∼5 × 106 TCID50 NAb NAb NAb
SARSa Calu-3 (Diff) ∼5 × 107 TCID50 2 × 102 TCID50 None None
SARSc HAE ∼3.5 × 104 PFU/mL 1.3 × 101 PFU/mL None None
SARSd HAE ∼5 × 106 PFU/mL ∼5 × 104 PFU/mL None None
229Ee HAE 1.05 × 104 FFU/mL 5.7 × 102 FFU/mL 9.3 × 102 FFU/mL 1 × 102 FFU/mL
RSVf HAE 1 × 107 PFU/mL None None None
PIVg HAE +++ –
a Tseng et al. (2005).
b Not applicable.
c Jia et al. (2005).
d This manuscript.
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escence detected both SARS-CoV antigen and the primary viral
eceptor, angiotensin 1 converting enzyme 2 (hACE2), colocal-
zed in infected Calu-3 cells suggesting that hACE2 was required
or SARS-CoV entry into Calu-3 cells. To confirm that hACE2
as the primary receptor, Calu-3 monolayers were preincubated
ith antisera directed against hACE2 prior to inoculation. Pre-
reatment of cultures with antisera directed against hACE2, but
ot irrelevant control sera resulted in a dose dependent reduc-
ion in viral titers, suggesting that SARS-CoV was dependent
n hACE2 for entry into Calu-3 cells.
To determine if SARS-CoV entry and release in Calu-3 cells
ere polarized, scanning confocal images of mock-infected
nd infected cells were taken and assembled to generate a
hree-dimensional image. hACE2 and SARS-CoV antigens
olocalized primarily at the apical surface of the cultures, sug-
esting that SARS-CoV entry and release may be restricted to
he apical surface of these cells. To further examine the polarity
f SARS-CoV infection and release, Calu-3 cells were cultured
n Transwell membranes for greater than 10 days, generating a
ulture of highly polarized cells connected by tight junctions and
isible microvilli. Cultures were then inoculated with SARS-
oV either via the apical or basolateral surfaces and media
arvested from both apical and basolateral surfaces and viral
iters assayed. Inoculation of the apical surface resulted in the
elease of virus from both the apical (5 × 107 TCID50, Table 1)
nd basolateral (2 × 102 TCID50, Table 1) surfaces, although
iral titers from the apical surface were four to five logs higher.
noculation of the basolateral surface of polarized Calu-3 cells
as not a productive route of infection. These studies demon-
trated that SARS-CoV could productively infect bronchial
pithelial cells, most likely using hACE2 as the primary receptor
or entry. Virus entry and release were most productive follow-
ng an apical route of inoculation suggesting a model for the
elease of large quantities of virus into the lumen of the lung,
hich could explain detection of virus in the lower airway and
ransmission to uninfected individuals (Table 1). However the
irect relevance of these results to SARS-CoV pathogenesis in
umans required a more relevant model of the human conduct-
ng airway, one that recapitulates the cell-type distribution of the
uman conducting airway epithelium.
a
o
l
c.2. 229E infection of human airway epithelial cell cultures
While the Calu-3 replication model provided clues about
ARS-CoV replication in homogenous epithelial cell types,
urther experiments require more sophisticated models that con-
ain multiple cell types that more faithfully represent those of
he human conducting airway epithelium. The human airway
pithelial cell culture system (HAE) is an in vitro model of the
uman airway epithelium. HAE recapitulate the morphological
nd physiological features of the human airway epithelium in
ivo and is comprised of ciliated, non-ciliated mucin-secreting
nd basal epithelial cells (Pickles et al., 1998; Zhang et al.,
002). The first human coronavirus strain demonstrated to infect
AE was HCoV strain 229E (Wang et al., 2000). To provide
lues for the potential routes of viral infection, HAE were first
xamined for the localization of the cellular receptor for 229E,
D13/aminopeptidase N that was detected exclusively at the
pical surface of well-differentiated HAE suggesting that a pri-
arily apical route of viral entry was utilized by this virus. To
etermine the most productive route of infection, the cultures
ere inoculated with 229E via both the apical and basolateral
urfaces. Titers from apical surface washes were a log greater fol-
owing apical, rather than basolateral inoculation demonstrating
hat the most productive route of inoculation and progeny virion
elease for 229E was via the apical surface of the epithelium
Table 1). This was the first demonstration of human coron-
virus infection of the human airway epithelial cell cultures, but
oronavirus infection of this model was not investigated further
ntil the identification of the SARS-CoV in 2002.
.3. SARS-CoV replication in human airway epithelial cell
ultures
The first studies with SARS-CoV in well-differentiated
AE focused on the localization of the SARS-CoV receptor,
ACE2 in this culture model and the polarity of virus entry
nd release (Jia et al., 2005). hACE2 was detected primarily
n the apical surface of well-differentiated HAE cultures, with
ittle to no staining detected on the basolateral surface. In
ontrast, undifferentiated cultures had little to no detectable
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Fig. 1. Growth kinetics of icSARS-CoV in human airway epithelial cells. To
determine viral growth kinetics of icSARS-CoV in HAE cultures over time,
icSARS-CoV was inoculated onto the apical surface of HAE cultures and apical
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aACE2 staining and as such infection of undifferentiated
ultures resulted in no productive virus replication. Receptor
ocalization of both coronavirus strains, SARS-CoV and 229E,
n the well differentiated HAE cultures favored an apical
oute of viral entry, suggesting that the lumenal surface of the
ungs were the most likely site of viral entry following human
nfection. Following apical inoculation, apical release titers
ere ∼3.5 × 104 PFU/mL while basolateral titers following
pical inoculation peaked at 1.3 × 101 PFU/mL (Table 1).
imilar to studies performed with the less pathogenic 229E
irus, inoculation of SARS-CoV onto the apical surface of
he well-differentiated HAE was the most productive route of
nfection and also the optimal site for progeny virion release
Table 1). However, further studies were required to identify
he target cell type for SARS-CoV infection and to determine
f hACE2 was the primary receptor for SARS-CoV entry into
he HAE or if additional co-receptor molecules were required.
. Results
.1. SARS-CoV growth kinetics in well-differentiated HAE
ultures
To determine the rate of virion release following SARS-
oV infection, well-differentiated HAE were inoculated via the
pical surface with SARS-CoV (MOI 1, strain Urbani). Api-
al surface washes were harvested daily for a total of 8 days
ost-inoculation, titered by plaque assay on Vero E6 cells and
he plaque forming units per mL (PFU/mL) per day plotted
Fig. 1A). Peak titers shed from the apical surface exceeded
06 PFU/mL, replication titers similar to that observed in Vero
6 cell monolayers. This is in contrast to the titers obtained
y Jia et al. (3.5 × 104), demonstrating that SARS-CoV replica-
ion could achieve levels detected in traditional cell monolayers.
owever, viral titers in the basolateral compartments were
ow with peak titers below 105 PFU/mL (Fig. 1B) again con-
rming that SARS-CoV entry and release of progeny virions
redominately occurred from the apical surface. While titers
f icSARS-CoV replication from the apical surface are con-
istently 106 and higher, we do see variation with replication
evels between patient codes. All HAE cultures are allowed
o mature for optimal levels of cilia on the ciliated cells, but
odes that have been matured for similar lengths of time can
ave different levels of icSARS-CoV replication. This may
eflect variations in hACE2 expression levels throughout HAE
ulture maturation and experiments are currently underway to
etermine the optimal time post-plating for hACE2 expres-
ion levels. Alternatively, virus replication may be influenced
y the presence of human susceptibility alleles or by the age
nd health status of the donor. Viral titers increased from 12
o 24 h, peaked by 48 h, and were constant through 120 h post-
noculation. By 144 h post-inoculation, viral titers decreased by
wo logs and remained low through 192 h (168 and 192 h, data
ot shown), suggesting that HAE could no longer support pro-
uctive infection, potentially reflecting the lack of new cells to
nfect.
t
t
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I
tashes (A) and basolateral media (B) collections were performed at the indicated
imes. The washes were serially diluted and titers assayed on Vero E6 cells. Titers
re expressed as PFU/mL.
.2. SARS-CoV targets ciliated cells in the HAE culture
ystem
Previous studies using the HAE model demonstrated that
ommon human respiratory viruses, e.g. human respiratory
yncytial virus (RSV) and human parainfluenza virus type
(PIV3) exclusively infected ciliated epithelial cell-types
aising the possibility of a role of these cell-types in the
athogenesis of respiratory virus infection (Zhang et al., 2002,
005). To determine the nature of the cell type(s) infected by
ARS-CoV, transmission electron microscopy was performed
n fixed cultures 48 h post-inoculation, the time point of peak
iral replication in the HAE cultures. Only ciliated cell-types
f the HAE inoculated with SARS-CoV contained classic
oronavirus cytoplasmic vesicles filled with viral particles
Fig. 2B, E, F). In addition, large numbers of viral particles
ere seen within the spaces between the microvilli/cilia shafts
s well as in the airway surface microenvironment (ASM)
hat surrounds the ciliated cells suggesting mechanisms for
he release of large quantities of SARS-CoV into the lumen
f the conducting airway during viral replication (Fig. 2C–F).
mmuno-EM detecting the structural spike protein confirmed
hat the particles detected in the ASM were indeed SARS-CoV
Fig. 2. Ultrastructural localization of SARS-CoV in HAE. Representative transmission electron microscopic photomicrographs of HAE infected with Urbani SARS-
CoV. (A) HAE inoculated with vehicle alone demonstrating the typical morphological features of the apical surfaces of ciliated cells with prominent cilia (black arrow
heads) and microvilli (arrows). (B–F) HAE inoculated with Urbani SARS-CoV 48 h before fixation and showing the presence of large numbers of virus particles
(open arrow heads) in vesicles inside the ciliated cells (B and E), and on the surface of ciliated cells (B–F). To confirm the observed virions were SARS-CoV,
immuno-EM was performed using polyclonal mouse antisera against S with secondary antibodies conjugated to 12 nm gold beads (D, open arrow heads indicate
virions, arrows indicate colloidal gold). SARS-CoV infection resulted in extrusion and shedding of infected ciliated cells into the airway surface microenvironment
(F). Similar observations were seen with HAE infected with icSARS-CoV and SARS-CoV GFP. Black arrowheads, cilia; black arrows, microvilli; open arrowhead,
virions; small arrow, immuno-EM colloidal gold.
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Fig. 3. hACE2 is the primary receptor for SARS-CoV entry into HAE. To assess
effects of pretreatment of HAE with receptor specific antisera on the growth
kinetics of SARS-CoV infection, HAE were pretreated with polyclonal or mon-
oclonal antisera directed against hACE2 (pACE2 and mACE2, respectively),
a cocktail of monoclonal antisera directed against DC-SIGN, DC-SIGNR, or
both (DCSIGN), combinations of these antisera (pACE2 + DCSIGN) or an anti-
MUC1 negative control antibody prior to inoculation with icSARS-CoV. Apical
washes at the indicated time points were serially diluted and assayed by plaque
assay on Vero E6 cells. Titers are represented by PFU/mL. Filled squares (black),
polyclonal hACE2 only; filled triangles (blue), DC-SIGN/DC-SIGNR mono-
clonal cocktail; open square (pink), monoclonal and polyclonal hACE2; open
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cirions (Fig. 2D). Therefore, SARS-CoV entry, replication, and
elease occurred exclusively in the ciliated cells of the HAE.
.3. SARS-CoV uses hACE2 exclusively to enter the ciliated
ells of the HAE
Jia et al. demonstrated exclusive apical staining of the SARS-
oV receptor molecule, hACE2, using their HAE model, which
s consistent with apical infection of ciliated cells. However,
dditional co-receptor molecules have been identified (DC-
IGN and DC-SIGNR) which might contribute to SARS-CoV
ntry into HAE (Jeffers et al., 2004; Marzi et al., 2004; Yang
t al., 2004). To determine if SARS-CoV infects ciliated cells
xclusively via an interaction with hACE2 we utilized an
ntibody blockade experiment using antisera directed against
ACE2, a method that has previously been shown to block the
nteraction of SARS-CoV with hACE2 in Vero E6 cells (Li et al.,
003). HAE were pre-incubated with polyclonal or monoclonal
ntisera directed against hACE2 (R&D Systems), a cocktail of
onoclonal antisera specific for DC-SIGN, DC-SIGNR or both,
r a control antibody that efficiently binds to the apical surface
f HAE (anti-tethered mucin MUC1, b27.29) for 2 h prior to
noculation with SARS-CoV (106 PFU/culture). Apical surface
ampling was performed from 2 to 36 h post-inoculation and
he samples titered by plaque assay in Vero E6 cells to deter-
ine viral growth kinetics. In the absence of antisera or in the
resence of control antisera SARS-CoV replicated to titers of
07 PFU/mL (Fig. 3). In contrast, in the presence of hACE2
olyclonal antisera alone or in combination with other antis-
ra, viral titers were reduced by at least two logs. Monoclonal
ntisera against hACE2 again failed to effect viral growth con-
rming that this antibody was not sufficient to block SARS-CoV
ntry into ciliated cells. Antisera directed against molecules
eported to function as SARS-CoV coreceptors, DC-SIGN and
C-SIGNR, did not affect infection of ciliated cells by SARS-
oV although it is not known whether these antibodies sterically
inder the interaction of SARS-CoV with these potential recep-
ors. Therefore, assessment of SARS-CoV infection by viral
rowth kinetics suggests that hACE2 is the predominant receptor
sed by SARS-CoV for infection of ciliated cell-types in HAE.
.4. SARS-CoV GFP replicates to wild type levels in three
ammalian cell lines
To directly observe the extent and kinetics of SARS-CoV
nfection of conducting airway cultures of model animal species
n real time, we constructed a recombinant SARS-CoV (SARS-
oV GFP) expressing the green fluorescent protein from the
a/7b open reading frame. To generate recombinant SARS-
oV GFP, the F plasmid of our infectious clone was mutated
o replace ORF 7a/7b with the GFP cDNA using the type IIS
estriction enzyme approach described previously (Yount et al.,
002). The mutated F plasmid was confirmed by sequence analy-
is and amplified in E. coli with wild type plasmids A through E.
ragments were then isolated by digestion with the appropriate
estriction enzyme, purified and ligated into a genomic length
DNA. The full-length cDNA was transcribed and genomic
c
l
circle (brown), no antibody; filled circle (red), monoclonal hACE2 only; open
iamond (aqua), polyclonal hACE2 and DC-SIGN/DC-SIGNR monoclonal
ocktail; open triangle (green), MUC 1.
ength RNA was co-electroporated with SARS-CoV nucleocap-
id (N) transcripts into Vero E6 cells. GFP-positive cells were
etected within 24 h of transfection and clarified supernatant
rom transfected cells when passed to fresh Vero E6 mono-
ayers resulted in viral cytopathic effect and green fluorescent
ells (Fig. 4A–C). The deletion of ORF 7a/7b did not obviously
ffect efficient SARS-CoV replication in tissue culture, similar
o observations with TGEV and MHV when GFP was inserted
nto accessory ORFs of these viruses (Baric and Sims, 2005;
urtis et al., 2002; Fischer et al., 1997; Sola et al., 2003). Prior
o further evaluation, five individual plaques of SARS-CoV GFP
ere isolated, amplified, and monitored for GFP fluorescence in
ddition to sequence confirmation of the mutation. All plaques
ontained GFP and had appropriate sequence mutations.To evaluate the growth kinetics of SARS-CoV GFP, growth
urves were generated for three different mammalian epithe-
ial cell lines. Monolayers of Vero E6, MA104, and CaCo2
ells were inoculated with Urbani, icSARS-CoV, and SARS-
Fig. 4. Growth kinetics of Urbani, icSARS-CoV and SARS-CoV GFP in Vero E6, MA104, and CaCo2 cells. To determine viral growth kinetics of the wild type and
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GARS-CoV GFP viruses, three cell types were infected: (A and D) Vero E6 (Af
nd D) CaCo2 (human, colorectal adenocarcinoma). Supernatant aliquots were
ero E6 cells. Titers are expressed as PFU/mL. Diamonds, Urbani; squares, icS
oV GFP (at an MOI 1), supernatant samples from the
ultures harvested at 2, 6, 12, 22, and 32 h post-inoculation
nd titers determined by plaque assay on Vero E6 cells
Fig. 4D). In Vero E6 cells, Urbani and SARS-CoV GFP grew
o titers of ∼2 × 107 PFU/mL, while icSARS-CoV peaked at
1.0 × 107 PFU/mL (Fig. 4D). For MA104 cells, all three
iruses grew to titers of (3–5) × 107 PFU/mL by 32 h post-
noculation (Fig. 4D), whereas in CaCo2 cells titers of all three
iruses were reduced by approximately one log compared to
A104 cells (Fig. 4D). In addition, SARS-CoV GFP replication
n HAE cultures was also similar to wild type Urbani (data not
hown). Overall, replacing ORF 7a/7b with GFP in SARS-CoV
FP was not detrimental to virus replication in any of the three
ell lines evaluated or HAE, thus providing a fluorescent marker
f virus infection with replication at wild-type virus levels.
.5. Susceptibility of animal airway epithelial cells to
ARS-CoV infectionSARS-CoV is an emerging pathogen whose natural host, the
hinese horseshoe bat has been identified (Guan et al., 2003;
au et al., 2005; Li et al., 2005; Poon et al., 2005). However,
n vivo studies have shown that SARS-CoV can replicate in
a
r
a
cgreen monkey, kidney); (B and D) MA104 (African green monkey, kidney); (C
sted at the indicated times post-infection, serially diluted and titers assayed on
CoV; triangles, SARS-CoV GFP.
he mouse, hamster, cat, civet cat, ferret, and non-human pri-
ate lung (Lau and Peiris, 2005; Li et al., 2005; Martina et
l., 2003; Osterhaus et al., 2004; Poon et al., 2005; Roberts et
l., 2005a,b). The civet cat likely represents an important reser-
oir for transmission to humans (Guan et al., 2003). Airway
pithelial cell cultures similar to the human model described here
ut derived from susceptible species may provide an important
omparative model to determine the mechanisms of pathogen-
sis and replication efficiency in alternative hosts. Moreover,
he availability of airway epithelium models from many differ-
nt animal hosts may provide a method for culturing zoonotic
athogens associated with human disease outbreaks. Towards
his goal we have successfully generated ciliated airway epithe-
ium models derived from tracheobronchial airway epithelium of
57 black mice (MAE), Golden Syrian hamsters (HmAE), and
hesus macaques (RhMAE). Representative data from HmAE
s shown in Fig. 5A–C. Inoculation of the apical surfaces of
hese cultures with SARS-CoV GFP indicated that SARS-CoV
FP replicated to some extent in ciliated cells of RhMAE, to
lesser in HmAE and to a much lesser extent in MAE, rep-
esentative data from the HmAE cultures are shown Fig. 5A
nd B. Again, although fewer cells were infected than HAE,
iliated epithelial cell-types were the predominant cell targets
Fig. 5. SARS-CoV GFP infection of hamster airway epithelial cell cultures. (A) Ciliated airway epithelial cell cultures were derived from hamster and inoculated
via the apical surface with SARS-CoV GFP (106 PFU). GFP fluorescent images recorded 48 h post-infection are shown. Original magnifications: 10×. (B) Growth
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ARS-CoV (Fig. 2B and C, Table 1). New emerging viruses
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dhe higher titers of SARS-CoV replication. Non-polarized cul-
ures primary human airway epithelial cells were not infected
y SARS-CoV, similar to results obtained by Jia et al. (2005).
nother human coronavirus, 229E, which primarily causes a
ild upper respiratory tract infection in humans, has been shown
o principally target ciliated epithelium, causing cell morphol-
gy alterations, dyskinesia and cilia dysfunction following HAE
nfection (Wang et al., 2000). However, shedding of infected
iliated cells (Fig. 2F), noted here during SARS-CoV infection,
as not reported following HCoV229E infection. In contrast
o other HCoV, SARS-CoV infection is associated with severe
typical pneumonia in adults. The major pathological findings
n autopsy suggests SARS-CoV involvement of type II pneu-
ocytes located in the alveoli as evidenced by detection of viral
NAs and EM detection of virus-like particles (Chen et al., 2003;
heung et al., 2004; Zhang et al., 2003a,b). Importantly, patients
ying early following SARS-CoV exposure show marked bron-
hiolar disease with respiratory epithelial cell necrosis, loss of
ilia, squamous metaplasia and intrabronchiolar fibrin deposits.
n fact it has been suggested that early diffuse alveolar dam-
ge as a consequence of SARS-CoV infection may initiate in
he respiratory bronchioles (Franks et al., 2003; Nicholls et al.,
003b). The data presented support the hypothesis that SARS-
oV efficiently infects and replicates in ciliated airway cells,
hich concomitantly express the principle SARS-CoV recep-
or, hACE2. Notably, antibodies against hACE2 efficiently block
nfection, replication, and spread of SARS-CoV in HAE (Fig. 3)
imilar to results reported in Vero E6 and 293 cells expressing
ACE2 (Li et al., 2003; Sui et al., 2004). Although DC-SIGN and
C-SIGNR also function as co-receptors or alternative receptors
or SARS-CoV docking and entry into some cell-types (Jeffers et
l., 2004; Marzi et al., 2004; Yang et al., 2004), in HAE, antibod-
es against DC-SIGN and DC-SIGNR did not inhibit SARS-CoV
nfection suggesting that these potential receptors were either
ess important than hACE2 for virus entry into ciliated cells or
hat these particular antibodies do not successfully block virus
ocking and entry in the presence of functional hACE2 (Fig. 3).
he significant reduction of SARS-CoV infection with hACE2
ntisera supports the hypothesis that hACE2 functions as the
ajor receptor for SARS-CoV infection of ciliated cells.
By EM, large numbers of virus particles, both released
rom infected cells and in budding vesicles being transported
o the lumenal surface were present both inside ciliated cells
nd in close proximity to the apical surface of ciliated cells
Fig. 2B–F). Abundant numbers of virus particles were also
rapped in cellular debris in the lumenal compartment suggesting
hat cell-associated virus might also contribute to SARS-CoV
pread between hosts. The mechanism that specifies the pre-
ominant polarized release of SARS-CoV virions is unclear,
ut releasing virus particles into the lumen of airways provides
means of propagating spread via interaction with potential
iral receptors also polarized to the lumenal surface of cil-
ated cells, i.e. hACE2. Similar findings were also reported
ith HCoV-229E (Wang et al., 2000). As recent reports sug-
est that HCoV-NL63 also uses hACE2 as a receptor for entry
nto cells, these data indicate that many coronaviruses target this
athway while replicating in the lung epithelium (Hofmann et
a
a
v
tl., 2005). EM also demonstrated extensive cytopathology and
acuolization of infected cells, suggesting that considerable cell-
ssociated virus may be shed from infected patients (Fig. 2F).
n addition, our data demonstrate that SARS-CoV assembly and
elease occurs via budding into internal vesicles that are trans-
orted to the cell surface (Fig. 2B and F). Ultimately, infection
esults in shedding of the ciliated cell itself and these cells often
ontain large quantities of virus (Fig. 2F).
The HAE culture model recapitulates not only the mor-
hological features of the human upper airway allowing
isualization of the high levels of replication and destructive
ature of SARS-CoV but also provides an excellent model for
tudying and comparing the physiological responses of the lung
o a large number of respiratory virus infections. A wide range of
echniques is available to determine the effect of respiratory virus
nfection on specific innate defense mechanisms of the airway
pithelium that are recapitulated in HAE. In a well ciliated HAE
ulture, mucus flows over the apical surface in a continuous cir-
ular pattern due to coordinated activity of cilial beat providing
n in vitro measure of mucociliary transport that approximates
ucociliary clearance in vivo (Matsui et al., 1998). Fluctuations
n the flow rate can be measured by observing the rotational
ow of fluorescent microspheres deposited on the apical sur-
ace. Destruction and shedding of ciliated cells lead to an overall
eduction in mucociliary transport, preventing the upper airway
rom effectively clearing viral pathogens. Another important
rotective component of the airway innate response to inhaled
athogens is the secretion into the airway lumen of highly gly-
osylated mucosubstances (e.g., MUC5AC and MUC5B) and
urfactant phospholipid-protein complexes (e.g., SP-A and SP-
) (Stonebraker et al., 2004). It is predicted that different mucin
pecies have distinct rheological/innate defense functions in the
irways while their overall function is to aid in the removal of
nfected cells and resolve injured epithelium. The composition
f the mucosubstance and surfactant production and the gen-
ral levels of production of both mucins and surfactants can be
sed to predict disease severity with a lack of production fol-
owing virus infection leading to reduced viral clearance with
reater severity of disease. Immune responses to SARS-CoV can
e assayed by sampling apical washes and basolateral media to
easure cytokine and interferon levels as has been noted follow-
ng RSV infection (Mellow et al., 2004). In addition, changes
n cellular mRNA and protein levels can be determined by tran-
criptional and proteomic profiles, respectively.
Damage to the epithelium following infection can be mon-
tored by determining levels of trans-epithelial resistance, a
easure of the integrity of the overall epithelium, as well as
evels of enzymes such as lactate dehydrogenase (LDH) that are
ndicators of tissue damage. It is probable that innate immune
unctions in the ciliated cell are critical in disease progression
s these cells likely represent initial targets of infection. Innate
mmune responses can be monitored in the HAE cultures to
etermine the pathological potential for wild type and attenu-
ted respiratory viruses in the cultures. This makes the HAE
n excellent model to evaluate live attenuated respiratory virus
accine replication and pathogenicity in the human lung prior
o phase one trials. Live attenuated vaccine candidate strains
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ell cultures to determine viral growth kinetics. Low levels of
eplication in the culture models would be consistent with lim-
ted replication in the airway of an animal model and would
ndicate an inadequate vaccine candidate, prior to in vivo stud-
es in animal models. HAE cultures provide a model system
o study respiratory virus replication and pathogenesis, innate
mmune responses as well as mechanical clearance of pathogens
rom the human conducting airway.
Several paradigms have been proposed to explain the mech-
nism for spread of SARS-CoV in the human lung. One model
uggests that SARS-CoV infects lung dendritic cells that trans-
ort virus to the alveolar regions allowing for infection of type
I pneumocytes. This model is based on studies in which den-
ritic cells were infected by SARS-CoV via an interaction with
ver expressed levels of DC-SIGN (Marzi et al., 2004; Yang et
l., 2004). An alternative model would predict that SARS-CoV
nfection and spread could occur through some component of the
espiratory epithelium. Indeed consideration of the early pathol-
gy of SARS-CoV observed in the bronchiolar regions and the
emonstration that SARS-CoV replicates efficiently in ciliated
ells isolated from nasal and tracheobronchial airway regions
hown here are supportive of this latter hypothesis. Moreover,
he uniform gradient of hACE2 expression throughout the con-
ucting airways of the human lung provides a suitable substrate
or repeated cycles of virus amplification and spread through-
ut the airways, ultimately spreading to some cell component of
he alveolus regions. Since specific airway epithelial cell-types
specially ciliated epithelial cell-types possess unique physio-
ogical and innate defense functions in the lung it is important to
etermine the airway cell tropism of SARS-CoV in the human
ung in order to understand the pathological consequences of
nfection of such cell-types.
The HAE culture systems is not only useful for examining the
eplication and pathogenesis of known respiratory pathogens,
ut can also be an excellent tool for amplifying newly identified
merging human viruses that may or may not replicate in tradi-
ional tissue culture models. The multiple cell types of the HAE
ulture system provide additional target cell populations for
ewly emerged viruses and these cultures can provide a resource
or the rapid amplification of newly identified viruses for future
tudy. Comparison studies of human versus avian influenza
trains on human tracheobronchial cell cultures have demon-
trated that the preferred sialic acid species for the respective
irus actually reside on different cell types, which can restrict
he amount of replication the avian virus can make prior to addi-
ional adaptation to the potential human host (Ibricevic et al.,
006; Matrosovich et al., 2004). Airway cultures from tracheo-
ronchial cells from a range of animal species have also been
stablished greatly increasing the number of viruses that can be
tudied, allowing the study and amplification of both zoonotic
nd human isolates. In addition, zoonotic viruses can be pas-
aged on human cultures to identify mutations that arise during
daptation providing a unique look at the evolution of potential
uman pathogenic strains. The transition of SARS-CoV from
ts zoonotic origin, likely the Chinese horseshoe bat, to animals
f the Chinese market place, such as the Himalayan and palm
F
Givet cat and raccoon dog, then to humans is an example of
hen the full potential of this model system can be utilized. We
elieve that HAE provide for numerous opportunities to study
he pathogenesis of coronaviruses and other important human
espiratory pathogens in a model reflecting much of the architec-
ure of the human airways as well as investigating the molecular
echanisms governing virus cross-species transmission.
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